Meeting Overview |
We are pleased to invite you to our satellite symposium, Answers to Important Questions About Biosimilar Antibodies, to be held on 22 March 2012 at the 17th Congress of the European Association of Hospital Pharmacists in Milan, Italy.
|
Date and Location | 22 March 2012
Space 1
MiCO (Milano Convention Centre)
Piazzale Carlo Magno, 1 and Viale Eginardo
20149 Milan, Italy
|
Target Audience |
This educational activity is specifically designed for pharmacists and other healthcare professionals interested in biosimilar antibodies.
|
Learning Objectives | After successful completion of this educational activity, participants should be able to:
-
Compare monoclonal antibodies to other biologic medicines, and explain the features that lend to the complexity of these molecules
-
Discuss the potential impact of biosimilar antibodies on clinical practice
-
Analyze potential risks involved in automatically substituting biosimilar antibodies for their originators
|
Faculty | Chair and moderator
Irene Krämer, PharmD, PhD
Johannes Gutenberg-University Hospital Medical Center
Mainz, Germany
Faculty
Leigh Revers, MA, DPhil
University of Toronto
Toronto, Ontario, Canada
Håkan Mellstedt, MD, PhD
Karolinska Institute
Stockholm, Sweden |
Agenda |
| 08.30 |
|
Welcome and introduction
|
| 08.35 |
|
Monoclonal antibodies: What makes them unique?
Leigh Revers, MA, DPhil
|
| 08.55 |
|
Q&A
|
| 09.00 |
|
Biosimilar antibodies: What are the clinical implications?
Håkan Mellstedt, MD, PhD
|
| 09.20 |
|
Q&A
|
| 09.25 |
|
Substitution of biosimilar antibodies: Could there be unintended consequences?
Irene Krämer, PharmD, PhD
|
| 09.45 |
|
Q&A
|
| 09.55 |
|
Take-home messages
|
|
|
|
|
Organizer | This meeting is a prIME Oncology activity.
|
Support | Support for this educational activity is provided by F. Hoffmann-La Roche Ltd.
|
|
